Feb 8 | News
SAN DIEGO (AP) — Diagnostics company Illumina Inc. again rejected a $5.7 billion offer from Roche AG on Tuesday, saying the Swiss drugmaker's bid was "grossly inadequate."
|
Jan 26 | News
Surprising results from two new studies may reopen debate about the value of Avastin for breast cancer. The drug helped make tumors disappear in certain women with early-stage disease, researchers found.
|
Jan 25 | News
Roche has offered to acquire all outstanding shares of Illumina for $44.50 per share in cash, or approximately $5.7 billion, to strengthen its position in the diagnostics field.
|
Jan 25 | News
The Facility of the Year Awards Judging Panel has named five Category Award Winners and selected one project for Special Recognition in the 2012 Facility of the Year Awards (FOYA) program.
|
Jan 17 | News
Constellation Pharmaceuticals, Inc., today announced that it has entered into a major strategic agreement with Genentech, a member of the Roche Group, to launch a broad collaboration based on the science of epigenetics and chromatin biology to discover and develop innovative treatments for cancer and other serious diseases.
|
Jan 14 | News
Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche's NimbleGen Custom Sequence Capture 385K...
|
Jan 9 | News
Xenon today announced a strategic alliance with Genentech, a member of the Roche Group, to discover and develop compounds and companion diagnostics for the potential treatment of pain.
|
Dec 9 2011 | News
Roche NimbleGen, Inc. and BGI, the world’s largest genomic organization, announced that they have developed a Major Histocompatibility Complex (MHC) region capture technology based on NimbleGen SeqCap EZ Choice Library, a revolutionary process for the enrichment of the MHC region....
|
Dec 9 2011 | News
Collaboration offers new hope for a potential treatment for the leading genetic cause of death in infants and toddlers
|
Dec 9 2011 | News
Roche, together with ETH Zurich (Swiss Federal Institute of Technology, Zurich), the University of Zurich (UZH) and the University Hospital Zurich (USZ) announced today the formation of an external academic translational research hub in Zurich.
|